The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Evidence against the presence of an anandamide transporter
Open accessAbstract
On the basis of temperature dependency, saturability, selective inhibition, and substrate specificity, it has been proposed that an anandamide transporter exists. However, all of these studies have examined anandamide accumulation at long time points when downstream effects such as metabolism and intracellular sequestration are operative. In the current study, we have investigated the initial rates (<1 min) of anandamide accumulation in neuroblastoma and astrocytoma cells in culture and have determined that uptake is not saturable with increasing concentrations of anandamide. However, anandamide hydrolysis, after uptake in neuroblastoma cells, was saturable at steady-state time points (5 min), suggesting that fatty acid amide hydrolase (FAAH) may be responsible for observed saturation of uptake at long time points. In general, arvanil, olvanil, and N -(4-hydroxyphenyl)arachidonylamide (AM404) have been characterized as transport inhibitors in studies using long incubations. However, we found these “transport inhibitors” did not inhibit anandamide uptake in neuroblastoma and astrocytoma cells at short time points (40 sec or less). Furthermore, we confirmed that these inhibitors in vitro were actually inhibitors of FAAH. Therefore, the likely mechanism by which the transport inhibitors raise anandamide levels to exert pharmacological effects is by inhibiting FAAH, and they should be reevaluated in this context. Immunofluorescence has indicated that FAAH staining resides mainly on intracellular membranes of neuroblastoma cells, and this finding is consistent with our observed kinetics of anandamide hydrolysis. In summary, these data suggest that anandamide uptake is a process of simple diffusion. This process is driven by metabolism and other downstream events, rather than by a specific membrane-associated anandamide carrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
Cravatt, B. F., Demarest, K., Patricelli, M. P., Bracey, M. H., Giang, D. K., Martin, B. R., & Lichtman, A. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161191698 · Cited by 1,310
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., & Piomelli, D. (1997) · Science · doi:10.1126/science.277.5329.1094 · Cited by 813
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
Deutsch, D. G., & Chin, S. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90486-g · Cited by 702
Self-citationCannabinoids control spasticity and tremor in a multiple sclerosis model
Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Huffman, J. W., & Layward, L. (2000) · Nature · doi:10.1038/35003583 · Cited by 532
Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling
Bracey, M. H., Hanson, M. A., Masuda, K. R., Stevens, R. C., & Cravatt, B. F. (2002) · Science · doi:10.1126/science.1076535 · Cited by 490
Molecular characterization of human and mouse fatty acid amide hydrolases
Giang, D. K., & Cravatt, B. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2238 · Cited by 429
Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes
Bisogno, T., Maurelli, S., Melck, D., De Petrocellis, L., & Di Marzo, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3315 · Cited by 369
De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J. B., Finazzi-Agrò, A., & Di Marzo, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008555200 · Cited by 355
Sugiura, T., Kobayashi, Y., Oka, S., & Waku, K. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0356 · Cited by 348
De Petrocellis, L., Bisogno, T., Davis, J. B., Pertwee, R. G., & Di Marzo, V. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02082-2 · Cited by 347
Hillard, C. J., Edgemond, W. S., Jarrahian, A., & Campbell, W. B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020631.x · Cited by 338
Egertová, M., Giang, D. K., Cravatt, B. F., & Elphick, M. R. (1998) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1998.0543 · Cited by 334
Membrane transport of long-chain fatty acids: evidence for a facilitated process
Abumrad, N., Harmon, C., & Ibrahimi, A. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33310-1 · Cited by 326
Self-citationStructural determinants for recognition and translocation by the anandamide transporter
Piomelli, D., Beltramo, M., Glasnapp, S., Lin, S. Y., Goutopoulos, A., Xie, X.-Q., & Makriyannis, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5802 · Cited by 268
Tsou, K., Nogueron, M. I., Muthian, S., Sañudo-Peña, M. C., Hillard, C. J., Deutsch, D. G., & Walker, J. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00700-9 · Cited by 240
Self-citationHillard, C. J., Wilkison, D. M., Edgemond, W. S., & Campbell, W. B. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00087-s · Cited by 233
Mechanisms of Endocannabinoid Inactivation: Biochemistry and Pharmacology
Giuffrida, A., Beltramo, M., & Piomelli, D. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29345-9 · Cited by 226
Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase
Deutsch, D. G., Omeir, R., Arreaza, G., Salehani, D., Prestwich, G. D., Huang, Z., & Howlett, A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00830-1 · Cited by 215
Self-citationThe fatty acid amide hydrolase (FAAH)
Deutsch, D. G., Ueda, N., & Yamamoto, S. (2002) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1054/plef.2001.0358 · Cited by 210
Self-citationThe Cellular Uptake of Anandamide Is Coupled to Its Breakdown by Fatty-acid Amide Hydrolase
Deutsch, D. G., Glaser, S. T., Howell, J. M., Kunz, J. S., Puffenbarger, R. A., Hillard, C. J., & Abumrad, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m003161200 · Cited by 206
Self-citationInhibitors of arachidonoyl ethanolamide hydrolysis.
Koutek, B., Prestwich, G. D., Howlett, A. C., Chin, S. A., Salehani, D., Akhavan, N., & Deutsch, D. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31599-5 · Cited by 201
Self-citationMaurelli, S., Bisogno, T., De Petrocellis, L., Di Luccia, A., Marino, G., & Di Marzo, V. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01311-3 · Cited by 199
Anandamide Hydrolysis by Human Cells in Culture and Brain
Maccarrone, M., van der Stelt, M., Rossi, A., Veldink, G. A., Vliegenthart, J. F. G., & Agrò, A. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.48.32332 · Cited by 197
The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes
Hillard, C. J., & Jarrahian, A. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00191-2 · Cited by 193
Melck, D., Bisogno, T., De Petrocellis, L., Chuang, H.-H., Julius, D., Bifulco, M., & Di Marzo, V. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1105 · Cited by 188
Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide
Maccarrone, M., Bari, M., Lorenzon, T., Bisogno, T., Di Marzo, V., & Finazzi-Agrò, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13484 · Cited by 184
Anandamide, an endogenous cannabinomimetic eicosanoid: ‘Killing two birds with one stone’
Di Marzo, V., & Fontana, A. (1995) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(95)90077-2 · Cited by 170
Interactions between synthetic vanilloids and the endogenous cannabinoid system
Di Marzo, V., Bisogno, T., Melck, D., Ross, R., Brockie, H., Stevenson, L., Pertwee, R., & De Petrocellis, L. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01175-2 · Cited by 158
Jonsson, K., Vandevoorde, S., Lambert, D. M., Tiger, G., & Fowler, C. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704199 · Cited by 158
Carrier-Mediated Uptake of the Endogenous Cannabinoid Anandamide in RBL-2H3 Cells
Rakhshan, F., Day, T. A., Blakely, R., & Barker, E. L. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35376-5 · Cited by 150
Role of Fatty Acid Amide Hydrolase in the Transport of the Endogenous Cannabinoid Anandamide
Day, T. A., Rakhshan, F., Deutsch, D. G., & Barker, E. L. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1369 · Cited by 139
Self-citationJarrahian, A., Manna, S., Edgemond, W. S., Campbell, W. B., & Hillard, C. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742597.x · Cited by 133
Search for endogenous ligands of the cannabinoid receptor
Mechoulam, R., Hanuš, L., & Martin, B. R. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90197-x · Cited by 127
Novel Inhibitors of Brain, Neuronal, and Basophilic Anandamide Amidohydrolase
PETROCELLIS, L. D., Melck, D. J., Ueda, N., Maurelli, S., Kurahashi, Y., Yamamoto, S., Marino, G., & Marzo, V. D. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6000 · Cited by 117
Substrate Specificity and Stereoselectivity of Rat Brain Microsomal Anandamide Amidohydrolase
Lang, W., Qin, C., Lin, S., Khanolkar, A. D., Goutopoulos, A., Fan, P., Abouzid, K. A. M., Meng, Z., Biegel, D., & Makriyannis, A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980461j · Cited by 116
From cannabis to cannabinergics
Goutopoulos, A., & Makriyannis, A. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00250-4 · Cited by 114
Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid
Hillard, C. J., & Campbell, W. B. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30024-9 · Cited by 109
Arachidonoyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase
Omeir, R. L., Chin, S. A., Hong, Y. H., Ahern, D. G., & Deutsch, D. G. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00181-5 · Cited by 99
Self-citationA Structure/Activity Relationship Study on Arvanil, an Endocannabinoid and Vanilloid Hybrid
Marzo, V. D., Griffin, G., PETROCELLIS, L. D., Brandi, I., Bisogno, T., Williams, W., Grier, M. C., Kulasegram, S., Mahadevan, A., Razdan, R. K., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.984 · Cited by 97
Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides
Patricelli, M. P., & Cravatt, B. F. (2001) · Vitamins and hormones · doi:10.1016/s0083-6729(01)62002-8 · Cited by 73
López-Rodríguez, M. L., Viso, A., Ortega‐Gutiérrez, S., Lastres‐Becker, I., González, S. R., Fernández‐Ruíz, J., & Ramos, J. A. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm015545y · Cited by 71
Fowler, C. J., & Jacobsson, S. O. P. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0357 · Cited by 69
Conformational Memories and the Endocannabinoid Binding Site at the Cannabinoid CB1 Receptor
Barnett‐Norris, J., Hurst, D. P., Lynch, D. L., Guarnieri, F., Makriyannis, A., & Reggio, P. H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0200761 · Cited by 64
Distribution and characterization of anandamide amidohydrolase in mouse brain and liver
Watanabe, K., Ogi, H., Nakamura, S., Kayano, Y., Matsunaga, T., Yoshimura, H., & Yamamoto, I. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00052-6 · Cited by 56
Ibuprofen Inhibits the Metabolism of the Endogenous Cannabimimetic Agent Anandamide
Fowler, C. J., Stenström, A., & Tiger, G. (1997) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1997.tb00291.x · Cited by 55
Jacobsson, S. O. P., & Fowler, C. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704029 · Cited by 55
Transport of Long-Chain Native Fatty Acids across Human Erythrocyte Ghost Membranes
Kleinfeld, A. M., Storms, S. D., & Watts, M. (1998) · Biochemistry · doi:10.1021/bi980301+ · Cited by 46
Cannabinoid Properties of Methylfluorophosphonate Analogs
Martin, B. R., Beletskaya, I., Patrick, G., Jefferson, R. G., Winckler, R., Deutsch, D. G., Marzo, V. D., Dasse, O. A., Mahadevan, A., & Razdan, R. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39191-8 · Cited by 46
Self-citationDeletion of a proline‐rich region and a transmembrane domain in fatty acid amide hydrolase1
Arreaza, G., & Deutsch, D. G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00774-7 · Cited by 31
Self-citation
Cited by
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,529
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090
Anandamide and vanilloid TRPV1 receptors
Ross, R. A. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705467 · Cited by 604
Metadata
- Authors
- Glaser, S. T., Abumrad, N. A., Fatade, F., Kaczocha, M., Studholme, K. M., & Deutsch, D. G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-03-24
- Volume
- 100
- Issue
- 7
- Pages
- 4269-4274
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2084652074
- Cited by
- 279
- References
- 51
- FWCI
- 22.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.